North Oaks, MN, United States of America

James A Halikas


Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1991-1995

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of James A Halikas

Introduction

James A Halikas is a notable inventor based in North Oaks, MN (US). He has made significant contributions to the field of psychotropic substances, holding a total of 4 patents. His work focuses on developing compounds that enhance learning and memory, showcasing his commitment to advancing scientific knowledge.

Latest Patents

Among his latest patents, Halikas has developed biologically active N-acylprolydipeptides that possess antiamnestic properties. These novel substances facilitate learning and memory, demonstrating psychotropic activity. The N-acyl-prolyldipeptides he invented have a specific formula that includes various alkyl and aryl groups, indicating a sophisticated understanding of chemical interactions. Additionally, he has worked on 1,2,3,4-tetrahydropyrrolo-[1,2-a]-pyrazine derivatives, which also exhibit psychotropic activity, particularly anxiolytic effects. These compounds and their acid addition salts are designed to provide therapeutic benefits.

Career Highlights

Halikas has had a distinguished career, contributing to research at the Russian-American Institute for New Drug Development and the University of Minnesota. His work in these institutions has allowed him to explore innovative drug development and contribute to the scientific community.

Collaborations

Throughout his career, Halikas has collaborated with notable colleagues, including Tatiana A Voronina and Sergei Borisovich Seredenin. These partnerships have likely enriched his research and expanded the impact of his inventions.

Conclusion

James A Halikas is a prominent inventor whose work in psychotropic substances has the potential to significantly influence the fields of learning and memory enhancement. His innovative patents and collaborations reflect his dedication to advancing scientific research and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…